Healthcare provider profile · identity verified

Matthew Waite

Family Practice · LAKESIDE, AZ · NPI 1760861082

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	493	146
Levothyroxine Sodium	Levothyroxine Sodium	458	116
Losartan Potassium	Losartan Potassium	384	109
Lisinopril	Lisinopril	351	100
Amlodipine Besylate	Amlodipine Besylate	319	85
Omeprazole	Omeprazole	316	95
Rosuvastatin Calcium	Rosuvastatin Calcium	284	86
Metformin Hcl	Metformin Hcl	190	52
Tamsulosin Hcl	Tamsulosin Hcl	169	53
Albuterol Sulfate Hfa	Albuterol Sulfate	151	62
Hydrochlorothiazide	Hydrochlorothiazide	151	42
Allopurinol	Allopurinol	149	45
Metoprolol Succinate	Metoprolol Succinate	146	38
Pantoprazole Sodium	Pantoprazole Sodium	131	39
Trazodone Hcl	Trazodone Hcl	130	41
Metformin Hcl Er	Metformin Hcl	125	34
Eliquis	Apixaban	117	31
Metoprolol Tartrate	Metoprolol Tartrate	116	39
Carvedilol	Carvedilol	113	31
Sertraline Hcl	Sertraline Hcl	106	26
Furosemide	Furosemide	101	38
Clopidogrel	Clopidogrel Bisulfate	99	34
Simvastatin	Simvastatin	99	28
Citalopram Hbr	Citalopram Hydrobromide	94	32
Gabapentin	Gabapentin	91	32
Glipizide	Glipizide	85	25
Glipizide Er	Glipizide	83	28
Montelukast Sodium	Montelukast Sodium	79	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	14
Amitriptyline Hcl	Amitriptyline Hcl	70	29
Pravastatin Sodium	Pravastatin Sodium	70	19
Escitalopram Oxalate	Escitalopram Oxalate	67	22
Synthroid	Levothyroxine Sodium	67	16
Potassium Chloride	Potassium Chloride	65	25
Propranolol Hcl	Propranolol Hcl	62	22
Alendronate Sodium	Alendronate Sodium	61	23
Pioglitazone Hcl	Pioglitazone Hcl	59	17
Valsartan	Valsartan	59	20
Meloxicam	Meloxicam	58	23
Famotidine	Famotidine	56	18
Atenolol	Atenolol	55	17
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	23
Prednisone	Prednisone	46	38
Triamcinolone Acetonide	Triamcinolone Acetonide	44	30
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	13
Naproxen	Naproxen	39	15
Trulicity	Dulaglutide	39	suppressed
Finasteride	Finasteride	38	13
Hydroxyzine Hcl	Hydroxyzine Hcl	36	13
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	11
Xarelto	Rivaroxaban	35	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	11
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	27
Bumetanide	Bumetanide	29	12
Lovastatin	Lovastatin	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	11
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Estradiol	Estradiol	28	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	14
Bupropion Xl	Bupropion Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Ozempic	Semaglutide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Digoxin	Digoxin	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	14
Januvia	Sitagliptin Phosphate	16	suppressed
Topiramate	Topiramate	16	suppressed
Lorazepam	Lorazepam	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Colchicine	Colchicine	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ibu	Ibuprofen	12	suppressed
Methimazole	Methimazole	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error